GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GPT Healthcare Ltd (BOM:544131) » Definitions » Cash Flow from Financing

GPT Healthcare (BOM:544131) Cash Flow from Financing : ₹-372 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GPT Healthcare Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Sep. 2024, GPT Healthcare paid ₹0 Mil more to buy back shares than it received from issuing new shares. It spent ₹33 Mil paying down its debt. It paid ₹0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent ₹123 Mil paying cash dividends to shareholders. It spent ₹7 Mil on other financial activities. In all, GPT Healthcare spent ₹163 Mil on financial activities for the six months ended in Sep. 2024.


GPT Healthcare Cash Flow from Financing Historical Data

The historical data trend for GPT Healthcare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GPT Healthcare Cash Flow from Financing Chart

GPT Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Cash Flow from Financing
-221.13 -571.61 -731.78 -485.01

GPT Healthcare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cash Flow from Financing Get a 7-Day Free Trial -385.85 -345.93 -299.84 -185.17 -186.95

GPT Healthcare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

GPT Healthcare's Cash from Financing for the fiscal year that ended in Mar. 2024 is calculated as:

GPT Healthcare's Cash from Financing for the quarter that ended in Sep. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-372 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GPT Healthcare  (BOM:544131) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

GPT Healthcare's issuance of stock for the six months ended in Sep. 2024 was ₹0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

GPT Healthcare's repurchase of stock for the six months ended in Sep. 2024 was ₹0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

GPT Healthcare's net issuance of debt for the six months ended in Sep. 2024 was ₹-33 Mil. GPT Healthcare spent ₹33 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

GPT Healthcare's net issuance of preferred for the six months ended in Sep. 2024 was ₹0 Mil. GPT Healthcare paid ₹0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

GPT Healthcare's cash flow for dividends for the six months ended in Sep. 2024 was ₹-123 Mil. GPT Healthcare spent ₹123 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

GPT Healthcare's other financing for the six months ended in Sep. 2024 was ₹-7 Mil. GPT Healthcare spent ₹7 Mil on other financial activities.


GPT Healthcare Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of GPT Healthcare's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


GPT Healthcare Business Description

Comparable Companies
Traded in Other Exchanges
Address
GPT Centre, JC-25, Sector III, Salt Lake, Kolkata, WB, IND, 700106
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.

GPT Healthcare Headlines

No Headlines